Author

David Andrew Sallman

Moffitt Cancer CenterORCID 0000-0003-0504-8233Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetics· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 3 Organism:human· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:DNA methylation· 1 Assay:imaging· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Abishar Cherukuri· 1 shared Albert Son· 1 shared Alejandro MariñosiD· 1 shared Aleksandra KopacziD· 1 shared Amy ChadburniD· 1 shared Amy F. McLemoreiD· 1 shared Arvin Ruiz· 1 shared Asmita MishraiD· 1 shared

Activity by Year

2021-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abishar Cherukuri

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 29, 2026

Persistent Malignant Stem Cells Drive Relapse After Transplantation in the Myelodysplastic Neoplasms

Benjamin R. Kroger, Roni Tamari, Carmelo Gurnari…·Stephen S. Chung

The paper detects malignant hematopoietic stem cells (HSCs) in myelodysplastic neoplasms (MDS) using low-input sequencing and shows they predict relapse after transplantation.

DOI 10.64898/2026.10.28.761431

humanDNA methylation

𝕏 PostBluesky

PathologyLeukemiaPeer-reviewedJun 30, 2026

Spatial remodeling of bone marrow architecture defines tissue-state signatures of disease activity and therapeutic response in myelodysplastic neoplasms

Ryan Nachman, Aleksandra Kopacz, Caitlin Unkenholz…·Sanjay S. Patel

This study uses spatial imaging to identify architectural changes in bone marrow that predict disease activity and response to therapy in myelodysplastic neoplasms.

1 citationtop 5%

humanimaging

𝕏 PostBluesky

GeneticsbioRxivPreprintSep 28, 2021

Clonal hematopoiesis is associated with increased toxicity in large B-cell lymphoma patients treated with chimeric antigen receptor T cell therapy

Neeraj Y. Saini, David M. Swoboda, Uri Greenbaum…·Koichi Takahashi

This study finds that clonal hematopoiesis mutations, particularly in DNMT3A, TET2, and ASXL1, are linked to increased toxicity in patients undergoing anti-CD19 CAR T-cell therapy for large B-cell lymphoma.

DOI 10.1101/2021.09.28.461858

humanwhole-exome sequencing

𝕏 PostBluesky